Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
2019 · Nature Communications · 149 citations
https://doi.org/10.1038/s41467-019-12472-3
K
Kevin Bellofatto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
747
Citations
13
h-index
15
i10-index
Kevin Bellofatto is an academic researcher from University Hospital of Geneva. The author has contributed to research in topics: Pancreatic function and diabetes & Diabetes and associated disorders & Diabetes Management and Research. The author has an h-index of 13, co-authored 34 publications.
ORCID: 0000-0001-7961-4539Papers by this author
worksMechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells
2021 · Stem Cell Reviews and Reports · 21 citations
https://doi.org/10.1007/s12015-021-10269-w
NLRP3 Inflammasome is Activated in Rat Pancreatic Islets by Transplantation and Hypoxia
2020 · Scientific Reports · 12 citations
https://doi.org/10.1038/s41598-020-64054-9
Author Correction: Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes
2020 · Nature Communications · 1 citations
https://doi.org/10.1038/s41467-020-19127-8
Spheroids Composed of Reaggregated Neonatal Porcine Islets and Human Endothelial Cells Accelerate Development of Normoglycemia in Diabetic Mice
2025 · Cells · 1 citations
https://doi.org/10.3390/cells14050366
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat